N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group. (2014)

First Author: Ng CS
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00228-014-1703-0

PubMed Identifier: 24888881

Publication URI: http://europepmc.org/abstract/MED/24888881

Type: Journal Article/Review

Volume: 70

Parent Publication: European journal of clinical pharmacology

Issue: 9

ISSN: 0031-6970